Posted by
Tirzepatide: A GLP-1 drug that also acts on separate receptors to promote weight loss
Tirzepatide, like semaglutide, is a GLP-1 drug used in diabetes treatment and for weight loss. Unlike semaglutide, it also acts on glucose-dependent insulinotropic polypeptide receptors, proving a second route to reducing appetite as a means to treat diabetes and promote weight loss.
Similar Posts
Showing 1440 posts similar to “Tirzepatide: A GLP-1 drug that also acts on separate receptors to promote weight loss”
You've reached the end.